Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

DENVER, January 2 /PRNewswire/ --

Medical Simulation Corporation announces the launch of the Edwards SAPIEN Transcatheter Heart Valve (THV) Training Program in Europe. Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, received CE Mark approval for European commercial sales of its Edwards SAPIEN transcatheter aortic heart valve with the RetroFlex transfemoral delivery system in September, 2007, and CE Mark for the Edwards SAPIEN valve with the Ascendra transapical delivery system in December, 2007.

OCEANSIDE, California, January 2 /PRNewswire/ --

Foamex Asia Co. Ltd. announced today that it has changed its name to "FOAMTEC INTERNATIONAL CO., LTD." The name change is being made in connection with the buy-out of Foamex International Inc.'s interest in the Company by Hua Kee Company Limited ("Hua Kee"). Hua Kee is the current and original partner in the joint venture. Following the buy-out, the company will be a wholly-owned subsidiary of Hua Kee.

PRINCETON, New Jersey, December 31 /PRNewswire/ --

Pharmasset, Inc. (Nasdaq: VRUS), a clinical stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections, reported audited financial results for the fiscal year ended September 30, 2007. Pharmasset reported a net loss attributable to common stockholders of US$6.8 million, or US$0.46 per share, as compared to a net loss attributable to common stockholders of US$12.4 million, or US$1.19 per share for the same period in 2006.

HATBORO, Pennsylvania, December 31 /PRNewswire/ --

IGCE '08, the International Gaming Conference & Expo (IGCE, scheduled for Lisbon, Portugal, April 22-24 of 2008 has emphasized its concentration on the legal aspects of the gaming and sports industries in an effort to avoid what a spokesperson for the organization has referred to as the "current, inevitable glut of conferences that are occurring on an international basis."

"IGCE is the conference division of The Sports Network, the premiere real-time sports wire service in the United States," stated Amanda Manero, Conference Coordinator for IGCE, "and their reputation for providing first class service and accommodation to their client base has extended itself with regard to the upcoming conference.

HATBORO, Pennsylvania, December 28 /PRNewswire/ --

It was announced today that the response from attendees registering for the International Gaming Conference & Expo (IGCE) in Lisbon, Portugal, April 22-24 of 2008 has been, according to a spokesperson for the Conference, 'over the top.'

LONDON, December 28 /PRNewswire/ --

A child's game will be the focal point of a serious campaign to avert a mass extinction of amphibian species when zoos around the world hold leapfrog events on Dec. 31 to usher in "the year of the frog." Beginning at the Auckland Zoo in New Zealand, and ending at The Living Desert in Palm Desert, California, zoo visitors will form leapfrog lines and hop over each other -- to stretch their legs, and to raise awareness.